CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: DR. KHALID MUBARAK AL-SHAFI

World / Europe

Britain approves Novavax COVID shot for 12-17 year-olds

Published: 26 Aug 2022 - 02:02 pm | Last Updated: 26 Aug 2022 - 02:02 pm
Reuters file photo

Reuters file photo

Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years.

The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medicines and Healthcare products Regulatory Agency (MHRA) said.

Britain in February cleared Novavax's two-dose vaccine, Nuvaxovid, for use in adults.